GDRX — GoodRx Holdings, Inc.

Nasdaq · Information Technology · IT Services · CIK 1809519 ·
Last close
$3.22
Market Cap
$337.17M
52W High
$3.31
52W Low
$2.27
ADV30
1,077,725
Next earnings
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 194,006,000 173,850,000 14,009,000 1,169,000 2,021,251,000 235,710,000 1,399,265,000
Dec 2025 194,785,000 177,321,000 22,683,000 5,425,000 1,404,058,000 261,820,000 787,796,000
Sep 2025 196,028,000 182,609,000 14,620,000 1,119,000 1,325,507,000 273,529,000 724,795,000
Jun 2025 203,070,000 189,720,000 26,809,000 12,843,000 1,318,706,000 281,318,000 675,675,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$167,904,000
Investing CF
$-119,960,000
Financing CF
$-234,470,000
CapEx
$-74,020,000
Dividends Paid
Buybacks
$-216,372,000
EPS Diluted TTM
$0.09
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,410,574,000
Inventory
Receivables
$254,869,000
ST Investments
EBIT TTM
$99,143,000
Pretax Income TTM
$56,538,000
Interest Exp TTM
$42,605,000
Analysts
13

Yahoo Snapshot (yfinance, live)

Total Revenue
$787,889,024
EBITDA
$109,413,000
Free Cash Flow
$84,616,376
Enterprise Value
$1,379,241,984
Total Cash
$235,710,000
Total Debt
$541,350,976
Shares Out
104,711,186
Trailing EPS
$0.06
Book Value
$1.84
ROE
3.2%
ROA
3.5%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 796,853,000 87,492,000 30,439,000 1,404,058,000 787,796,000 167,904,000
Dec 2024 792,324,000 65,846,000 16,390,000 1,388,067,000 663,409,000 183,892,000
Dec 2023 750,265,000 -27,007,000 -8,868,000 1,588,800,000 826,842,000 138,292,000
Dec 2022 766,554,000 1,738,000 -32,828,000 1,604,631,000 789,804,000 146,780,000

TTM Snapshot

Revenues TTM
$562,527,000
NetIncome TTM
$-76,264,000
OpCashFlow TTM
$0
Assets (Latest)
$1,388,067,000
Forward EPS
$0.36

Peers — same industry

TickerNameMarket CapLastDaily %
TLS TELOS CORP $330.70M $4.42
NRDS NERDWALLET, INC. $327.83M $9.61
AIAI AIAI Holdings Corp $325.55M $4.63
SOHU Sohu.com Ltd $351.93M $13.50
CCIX Churchill Capital Corp IX/Cayman $320.69M $10.88

News headlines (Yahoo Finance, 1h cache)

1 Cash-Producing Stock for Long-Term Investors and 2 We Avoid
2026-07-24 10:33 · Yahoo
GoodRx (GDRX): Buy, Sell, or Hold Post Q1 Earnings?
2026-07-21 15:34 · Yahoo
1 Profitable Stock for Long-Term Investors and 2 Facing Challenges
2026-07-17 09:29 · Yahoo
Stocks making big moves yesterday: RXO, Progyny, Cigna, GoodRx, and Domino's
2026-07-14 20:07 · Yahoo
GoodRx (GDRX) Stock Trades Up, Here Is Why
2026-07-13 23:50 · Yahoo
GoodRx Holdings (GDRX) Pharma Growth Story Meets A Small Fair Value Gap
2026-07-12 05:07 · Yahoo
GoodRx (GDRX) Stock Looks Full On Earnings But Mixed On Value
2026-07-11 07:10 · Yahoo
GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call
2026-07-09 20:05 · Yahoo
1 Mooning Stock to Target This Week and 2 That Underwhelm
2026-07-09 10:05 · Yahoo
GoodRx (GDRX) Upgraded to Buy: What Does It Mean for the Stock?
2026-07-08 16:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.